Psilocybin & Bipolar Disorder: Weighing the Evidence on Risks and Reported Benefits
A thorough examination of what the largest available dataset — an international survey of 541 people with bipolar disorder who have used psilocybin — reveals about the balance of benefits and risks, including the documented incidence of manic episodes and what clinical researchers now recommend for this population.
Content Coming Soon
This resource is being prepared and will be available shortly.
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar.
Morton, E., Sakai, K., Ashtari, A., Pleet, M., Michalak, E. E., & Woolley, J. (2023). Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. Journal of Psychopharmacology, 37(1), 49–60. https://doi.org/10.1177/02698811221131997
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.